Climb Bio CLYM
NASDAQ CLYM
$11.07 -0.40 (-3.49%)
At close: Oct 1, 2026 · 4:00 PM EDT

Climb Bio (CLYM) Non Operating Income (2024 - 2026)

Updated

Climb Bio (CLYM) recorded Non Operating Income of $1.86 million in Q2 2026, down 7.5% from $2.01 million a year earlier but up 25.0% from the prior quarter.

Analysis

Climb Bio (CLYM) Non Operating Income (2024 - 2026) Analysis & Trends

On a TTM basis, Climb Bio's Non Operating Income came in at $7.37 million as of Jun 30, 2026, down 14.0% year-over-year.

  • Quarterly Non Operating Income has ranged from $1.48 million in Q2 2024 to $2.84 million in Q3 2024 over the past five years.
  • On a year-over-year basis, Non Operating Income rose in 1 of the last four quarters, with an average decline of 8.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Climb Bio 873.49 Mn 873.49 Mn - 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.86 Mn
Mar 31, 2026 1.49 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 2.24 Mn
Sep 30, 2024 2.84 Mn
Jun 30, 2024 1.48 Mn
API Access

Climb Bio Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CLYM&period=max&api_key=YOUR_API_KEY